[HTML][HTML] Challenges in the management of giant intraductal breast papilloma

Y Fatemi, R Hurley, C Grant, T Henrichsen… - Clinical Case …, 2015 - ncbi.nlm.nih.gov
Intraductal papillomas are relatively common benign breast lesions, and represent about 5%
of proliferative benign breast lesions [1]. They may clinically present either as …

[HTML][HTML] Papillary neoplasms of the breast including upgrade rates and management of intraductal papilloma without atypia diagnosed at core needle biopsy

E Brogi, M Krystel-Whittemore - Modern Pathology, 2021 - Elsevier
Papillary neoplasms of the breast are a heterogeneous group of epithelial tumors nearly
entirely composed of papillae. Their classification rests on the characteristics of the …

Benign breast papillary lesions diagnosed on core biopsy: upgrade rate and risk factors associated with malignancy on surgical excision

C MacColl, A Salehi, S Parpia, N Hodgson… - Virchows Archiv, 2019 - Springer
Abstract Evaluation of radiologically detected breast lesions is a common task in surgical
pathology. Some benign lesions on biopsy are associated with an upgrade to in situ or …

An international multicenter review of the malignancy rate of excised papillomatous breast lesions

NM Foley, JM Racz, Z Al-Hilli, V Livingstone… - Annals of surgical …, 2015 - Springer
Background Papillary lesions of the breast are a relatively rare, but heterogeneous group
ranging from benign to atypical and malignant. Debate exists regarding the optimal …

Papillary Lesions of the Breast at Percutaneous Core-Needle Biopsy1

CL Mercado, D Hamele-Bena, SM Oken, CI Singer… - Radiology, 2006 - pubs.rsna.org
Purpose: To retrospectively review the imaging and histologic findings in patients in whom a
benign papillary lesion was diagnosed at core-needle breast biopsy. Materials and …

Breast papillomas in the era of percutaneous needle biopsy

V Sohn, J Keylock, Z Arthurs, A Wilson… - Annals of surgical …, 2007 - Springer
Background The significance of breast papillomas detected on core needle biopsy (CNB)
remains unclear. While those associated with malignancy or atypia are excised, no clear …

The incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in situ in patients with intraductal papilloma without atypia on core biopsy: results …

F Nakhlis, GM Baker, M Pilewskie, R Gelman… - Annals of surgical …, 2021 - Springer
Background Available retrospective data suggest the upgrade rate for intraductal papilloma
(IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in …

Should we excise? Are there any clinical or histologic features that predict upgrade in papillomas, incidental or non-incidental?

M Zaleski, YA Chen, AL Chetlen, J Mack, L Xu… - Annals of Diagnostic …, 2018 - Elsevier
The clinical decision to excise intraductal papilloma (IDP) without atypia diagnosed on
biopsy remains controversial. We sought to establish clinical and histologic predictors (if …

Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: rate of malignancy based on subsequent surgical excision

JM Chang, W Han, WK Moon, N Cho, DY Noh… - Annals of surgical …, 2011 - Springer
Purpose To prospectively determine the rate of malignancy after surgery in papillary lesions
initially diagnosed at ultrasound (US)-guided 11-gauge vacuum-assisted breast biopsies …

Diagnosis of papillary breast lesions on core needle biopsy: upgrade rates and interobserver variability

L Qiu, DD Mais, M Nicolas, J Nanyes… - … Journal of Surgical …, 2019 - journals.sagepub.com
The histologic distinction between papillary breast lesions remains challenging, especially
with core biopsy (CB) specimens. A retrospective review of the clinical, imaging, and …